{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:45:50Z","timestamp":1793324750008,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Medical and Health Science Project of Zhejiang Province","award":["2016151091"],"award-info":[{"award-number":["2016151091"]}]},{"name":"Education Project of Zhejiang Province Office","award":["Y201328272"],"award-info":[{"award-number":["Y201328272"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12886-016-0248-7","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T11:41:59Z","timestamp":1464262919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications"],"prefix":"10.1186","volume":"16","author":[{"given":"Lan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"issue":"2","key":"248_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08820530902800801","volume":"24","author":"TA Shazly","year":"2009","unstructured":"Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009;24(2):113\u201321.","journal-title":"Semin Ophthalmol"},{"issue":"5","key":"248_CR2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.preteyeres.2007.06.001","volume":"26","author":"SS Hayreh","year":"2007","unstructured":"Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26(5):470\u201385.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"248_CR3","first-page":"131","volume":"67","author":"TM Kuang","year":"2004","unstructured":"Kuang TM, Liu CJ, Chou CK, Hsu WM. Clinical experience in the management of neovascular glaucoma. J Chin Med Assoc. 2004;67(3):131\u20135.","journal-title":"J Chin Med Assoc"},{"issue":"6398","key":"248_CR4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359(6398):843\u20135.","journal-title":"Nature"},{"issue":"22","key":"248_CR5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"248_CR6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0161-6420(98)92782-8","volume":"105","author":"RC Tripathi","year":"1998","unstructured":"Tripathi RC, Li J, Tripathi BJ, Chalam KV, Adamis AP. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. Ophthalmology. 1998;105(2):232\u20137.","journal-title":"Ophthalmology"},{"issue":"14","key":"248_CR7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432\u201344.","journal-title":"N Engl J Med"},{"issue":"14","key":"248_CR8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1419\u201331.","journal-title":"N Engl J Med"},{"issue":"11","key":"248_CR9","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2337\/dc10-0493","volume":"33","author":"P Massin","year":"2010","unstructured":"Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care. 2010;33(11):2399\u2013405.","journal-title":"Diabetes Care"},{"issue":"6","key":"248_CR10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","volume":"117","author":"DM Brown","year":"2010","unstructured":"Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117(6):1124\u201333.","journal-title":"Ophthalmology"},{"issue":"5","key":"248_CR11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/IAE.0b013e3181679c0b","volume":"28","author":"JP Ehlers","year":"2008","unstructured":"Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab\/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina. 2008;28(5):696\u2013702.","journal-title":"Retina"},{"issue":"9","key":"248_CR12","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2008.02.026","volume":"115","author":"T Wakabayashi","year":"2008","unstructured":"Wakabayashi T, Oshima Y, Sakaguchi H, Ikuno Y, Miki A, Gomi F, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 2008;115(9):1571\u201380.","journal-title":"Ophthalmology"},{"issue":"5","key":"248_CR13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IJG.0b013e3180457c47","volume":"16","author":"S Yazdani","year":"2007","unstructured":"Yazdani S, Hendi K, Pakravan M. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma. J Glaucoma. 2007;16(5):437\u20139.","journal-title":"J Glaucoma"},{"issue":"3","key":"248_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/08820538.2012.730103","volume":"28","author":"JR SooHoo","year":"2013","unstructured":"SooHoo JR, Seibold LK, Kahook MY. Recent advances in the management of neovascular glaucoma. Semin Ophthalmol. 2013;28(3):165\u201372.","journal-title":"Semin Ophthalmol"},{"issue":"10","key":"248_CR15","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0161-6420(01)00775-8","volume":"108","author":"JA Sivak-Callcott","year":"2001","unstructured":"Sivak-Callcott JA, O\u2019Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108(10):1767\u201376.","journal-title":"Ophthalmology"},{"issue":"12","key":"248_CR16","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jamaophthalmol.2013.5059","volume":"131","author":"E Rulli","year":"2013","unstructured":"Rulli E, Biagioli E, Riva I, Gambirasio G, De Simone I, Floriani I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131(12):1573\u201382.","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"248_CR17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/IJG.0b013e31819c4a07","volume":"18","author":"YH Chen","year":"2009","unstructured":"Chen YH, Lu DW, Cheng JH, Chen JT, Chen CL. Trabeculectomy in patients with primary angle-closure glaucoma. J Glaucoma. 2009;18(9):679\u201383.","journal-title":"J Glaucoma"},{"issue":"7070","key":"248_CR18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/nature04482","volume":"438","author":"RF Gariano","year":"2005","unstructured":"Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature. 2005;438(7070):960\u20136.","journal-title":"Nature"},{"issue":"11","key":"248_CR19","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.08-2662","volume":"50","author":"Z Li","year":"2009","unstructured":"Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, Dewerchin M, et al. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2009;50(11):5217\u201325.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"248_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2011.03.013","volume":"152","author":"R Mathew","year":"2011","unstructured":"Mathew R, Barton K. Anti--vascular endothelial growth factor therapy in glaucoma filtration surgery. Am J Ophthalmol. 2011;152(1):10\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"248_CR21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ICU.0b013e3283360aad","volume":"21","author":"MB Horsley","year":"2010","unstructured":"Horsley MB, Kahook MY. Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol. 2010;21(2):112\u20137.","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"248_CR22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00006982-200603000-00016","volume":"26","author":"RL Avery","year":"2006","unstructured":"Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina. 2006;26(3):352\u20134.","journal-title":"Retina"},{"issue":"2","key":"248_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/bjo.2008.145714","volume":"93","author":"S Grover","year":"2009","unstructured":"Grover S, Gupta S, Sharma R, Brar VS, Chalam KV. Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma. Br J Ophthalmol. 2009;93(2):273\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"248_CR24","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1167\/iovs.08-2055","volume":"49","author":"A Klettner","year":"2008","unstructured":"Klettner A, Roider J, Klettner A, Roider J. Comparison of bevacizumab, ranibizumab, and pegaptanib in vitro: efficiency and possible additional pathways. Invest Ophthalmol Vis Sci. 2008;49(10):4523\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"248_CR25","first-page":"CD007920","volume":"10","author":"A Simha","year":"2013","unstructured":"Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2013;10:CD007920.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"248_CR26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IJG.0b013e3182946398","volume":"23","author":"H Elmekawey","year":"2014","unstructured":"Elmekawey H, Khafagy A. Intracameral ranibizumab and subsequent mitomycin C augmented trabeculectomy in neovascular glaucoma. J Glaucoma. 2014;23(7):437\u201340.","journal-title":"J Glaucoma"},{"issue":"1","key":"248_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40123-015-0033-3","volume":"4","author":"N Kitnarong","year":"2015","unstructured":"Kitnarong N, Sriyakul C, Chinwattanakul S. A Prospective Study to Evaluate Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma. Ophthalmol Ther. 2015;4(1):33\u201341.","journal-title":"Ophthalmol Ther"},{"issue":"15","key":"248_CR28","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.4103\/0366-6999.161371","volume":"128","author":"XJ Li","year":"2015","unstructured":"Li XJ, Yang XP, Li QM, Wang YY, Lyu XB. Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage. Chin Med J (Engl). 2015;128(15):2078\u201383.","journal-title":"Chin Med J (Engl)"},{"issue":"10","key":"248_CR29","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s00417-013-2428-y","volume":"251","author":"J Luke","year":"2013","unstructured":"Luke J, Nassar K, Luke M, Grisanti S. Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series. Graefes Arch Clin Exp Ophthalmol. 2013;251(10):2403\u201313.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"248_CR30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1442-9071.2012.02836.x","volume":"41","author":"RU Desai","year":"2013","unstructured":"Desai RU, Singh K, Lin SC. Intravitreal ranibizumab as an adjunct for Ahmed valve surgery in open-angle glaucoma: a pilot study. Clin Experiment Ophthalmol. 2013;41(2):155\u20138.","journal-title":"Clin Experiment Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0248-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:05:23Z","timestamp":1498316723000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-016-0248-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1186\/s12886-016-0248-7","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]},"article-number":"65"}}